Life Science REIT more than doubled its portfolio valuation over its first six months of operation following an impressive spending spree. But profit and revenue are still subdued as the REIT continues its growth phase. The portfolio was valued at
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
Register
Find Out More